HOME - 40th Annual CFS®: Innovative Cancer Therapy for Tomorrow®
Shift to targeted therapies continues in relapsed/refractory indolent non-Hodgkin lymphoma
NOVEMBER 9 – 11, 2022
SABCS 2022: POSITIVE study shows that interruption of endocrine therapy in breast cancer patients planning pregnancy does not result in worse short-term disease relapse - VHIO
AACI Update | June 2022
KSC Symposium 2022 on Vimeo
RPA Pancreatic Cancer Management Symposium 2022
41st Annual CFS®: Innovative Cancer Therapy for Tomorrow®
2022 SABCS: Is There an Option to Omit Chemotherapy?
BCRF Investigators Discuss the Latest in Research at Symposium | BCRF
Cuidado Oral Para Pacientes de Cáncer — AYA USC
Media Centre | Hong Kong Breast Cancer Foundation - Live Symposium on Breast Health Education 2023
MSK's Research Roundup at AACR 2022: Targeted Therapy for Lung Cancer, Using Statins With a Breast Cancer Drug, and Diagnosing Blood Cancer | Memorial Sloan Kettering Cancer Center
The Tisch Cancer Institute on Twitter: "Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow, Nov 9-11 https://t.co/eLK0F7uaB1 Co-chairs: @AjaiChari, @benlevylungdoc, Dr. Tiffany Traina @ChemotherapyFnd https://t.co/BYmfO266F1 ...
Virtual Appendix Cancer Multi-Regional Symposium - ACPMP
Hong Kong Breast Cancer Foundation on Twitter: "In the Breast Cancer Survivorship Month, the Foundation will hold its third “Symposium on Breast Health Education 2022” on 28 May (Saturday). 😍 Experts in
38th Annual CFS®: Innovative Cancer Therapy for Tomorrow®
New therapy to avoid chemotherapy in lung cancer | I3PT Parc Taulí
More Funding of Cancer Research Crucial for Continued Advancements
AICR Research Conference 2022 - American Institute for Cancer Research
HOME - 39th Annual CFS®: Innovative Cancer Therapy for Tomorrow®
Researchers discover the mechanism by which tumor cells become resistant to chemotherapy in colorectal cancer - VHIO
Chemotherapy Foundation Symposium (Nov 2023), New York USA - Conference
